may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
over years of research, scientists discovered that cgrp helps transmit pain signals in the brain..
.
the report "correctly points out that there really was no playbook for dealing with what was an unprecedented health crisis," san diego mayor kevin faulconer said.